COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness

Robin Cherian, Bharatendu Chandra, Moon Ley Tung, Alain Vuylsteke

Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020
Journal Issue: August
Disease area: Respiratory critical care

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Robin Cherian, Bharatendu Chandra, Moon Ley Tung, Alain Vuylsteke. COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness. Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
COPD mechanisms: novel aspects and implications for new therapies
Source: ERS Live 2007
Year: 2007

Revising our approach to conducting therapeutic clinical research in COPD
Source: Eur Respir J, 51 (2) 1702712; 10.1183/13993003.02712-2017
Year: 2018

A pragmatic guide to choosing biologic therapies in severe asthma
Source: Breathe, 17 (4) 210144; 10.1183/20734735.0144-2021
Year: 2021

COPD – will new insights into molecular pathology define new therapies?
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014

Does acute and persistent metabolic dysregulation in COVID-19 point to novel biomarkers and future therapeutic strategies?
Source: Eur Respir J, 59 (2) 2102417; 10.1183/13993003.02417-2021
Year: 2022

HOPE-BAL: A novel tool to expand the methodological capabilities in pulmonary research
Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Year: 2012

Current and emerging approaches to the genetic diagnosis of chILDs
Source: International Congress 2014 – Interstitial lung disease (ILD) in children
Year: 2014

Halotherapy and Covid-19: an oppinion for a possible future prevention approach
Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors
Year: 2021

Bronchiectasis: state-of-the-art diagnostic and therapeutic approaches
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021

Clinical implications and novel therapies
Source: International Congress 2018 – Accelerated ageing in lungs
Year: 2018

From the bedside: upcoming new clinical strategies
Source: International Congress 2016 – Scientific Year in Review 2016
Year: 2016

The paradoxes of asthma management: time for a new approach?
Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017
Year: 2017

Clinical implications and opportunities for new drug therapies
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
Year: 2008

The concept of control in COPD: a new proposal for optimising therapy
Source: Eur Respir J 2014; 44: 1072-1075
Year: 2014

Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice
Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies
Year: 2009

Clinical implications of the new concepts regarding COPD pathophysiology
Source: Annual Congress 2008 - New insights into COPD pathophysiology
Year: 2008

Is poor asthma self-management due to failure to recognise symptoms or failure to act? Novel insights from mining large-scale clinical observational study
Source: International Congress 2019 – M-health/e-health II
Year: 2019

From staging to therapy: implications of the new staging system with a focus on multi-modal treatment options
Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Year: 2017

The future: treating specific endotypes
Source: International Congress 2015 – PG2 Asthma and COPD
Year: 2015